propidium has been researched along with docetaxel anhydrous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Motwani, M; Rizzo, C; Schwartz, GK; She, Y; Sirotnak, F | 1 |
| Barnetson, R; Doyle, B; Fleming, J; Kozielski, F; Leung, HY; Robson, CN; Singh, BL; Stockley, J; Wiltshire, C | 1 |
| Kong, CC; Liu, XD; Song, CY; Tian, X | 1 |
3 other study(ies) available for propidium and docetaxel anhydrous
| Article | Year |
|---|---|
Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cyclin B; Cyclin B1; Docetaxel; Drug Synergism; Enzyme Inhibitors; Flavonoids; Flow Cytometry; Humans; Immunoblotting; In Vitro Techniques; Mitosis; Neoplasm Transplantation; Piperidines; Propidium; Retinoblastoma Protein; Stomach Neoplasms; Taxoids; Time Factors | 2003 |
Docetaxel-resistant prostate cancer cells remain sensitive to S-trityl-L-cysteine-mediated Eg5 inhibition.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cysteine; Docetaxel; Drug Screening Assays, Antitumor; Humans; Kinesins; Male; Propidium; Prostatic Neoplasms; Taxoids; Up-Regulation | 2010 |
Bufalin Induces Programmed Necroptosis in Triple-Negative Breast Cancer Drug-Resistant Cell Lines through RIP1/ROS-Mediated Pathway.
Topics: Antioxidants; Apoptosis; Bufanolides; Caspase 3; Cell Line; Cell Line, Tumor; Cysteine; Docetaxel; Doxorubicin; Fluorescein-5-isothiocyanate; Humans; Necroptosis; Propidium; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor; Triple Negative Breast Neoplasms; Tumor Necrosis Factor-alpha | 2022 |